Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live! Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, […]

F2F Consortium Meeting in Madrid The GUIDE.MRD (Guiding multi-modal therapies against MRD by liquid biopsies) consortium partners met for the first face-to-face annual meeting […]

EuropaColon Portugal Launched Support Line for Carers The data from the Caring for Informal Carers Movement surveys show that there are many issues facing these carers in Portugal, but one gap that s […]

DiCE Participants Complete Patient Expert Training We are thrilled to announce that two participants from Digestive Cancers Europe (DiCE) completed the EUPATI Patient Expert Training Programme in […]

New Expert Advisor on CRC Screening We are delighted to welcome Dr. Carlo Senore as our new advisor for colorectal cancer screening. Dr. Senore brings a wealth of expertise to our […]

Understanding Metastatic Colorectal Cancer: A Call to Awareness on World Metastatic Colorectal Cancer Day

DiCE Supports MOs Training Opportunity As an integral part of our commitment to patient care, we are pleased to inform you that DiCE will award two grants to DiCE Full members who are […]

Economist Impact: World Cancer Series Europe On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly supporting […]

Do You Dare to Think Differently about Cancer?

Promising Approach in Treating Rectal Cancer: Rethinking Radiation Before Surgery Radiation combined with chemotherapy, also known as chemoradiotherapy, is routinely given to people with rectal cancer whose tumours can be removed […]

Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX […]

DIPLOMA Trial: Minimally Invasive Surgery is an Effective Treatment Option for Early-Stage Pancreatic Cancer A notable study, DIPLOMA, led by Abu Hilal, M.D., Ph.D., of the Istituto Ospedaliero Fondazione Poliambulanza in Brescia, Italy, involved a large […]

Personalized mRNA Pancreatic Cancer Vaccine Shows Promising Results in Small Trial Messenger RNA (mRNA) vaccines – famous for preventing symptomatic infection of COVID-19—are starting to show some promise against pancreatic c […]

ESMO Study Confirms Precision Oncology Remains Largely Inaccessible to European Cancer Patients As a European umbrella organisation, DiCE is vocal in addressing the disparities associated with cancer patients’ access to precision medicine […]

Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including […]

RWE Research in mCRC In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the […]

Manifesto for a Healthier Europe DiCE, together with the EU Health Coalition, urges future EU leaders to prioritise health and life sciences. Ahead of next year’s European […]

EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic […]

Updates in Oesophageal and Gastric Cancer Research, Summer 2023